GVHD
Clinical trials for GVHD explained in plain language.
Never miss a new study
Get alerted when new GVHD trials appear
Sign up with your email to follow new studies for GVHD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo may shield transplant patients from debilitating immune attack
Disease control CompletedThis study tested whether a combination of two drugs, cyclophosphamide and abatacept, could lower the chance of developing chronic graft-versus-host disease (GVHD) after a stem cell transplant. GVHD happens when donor cells attack the patient's body. The trial included 43 adults …
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: Dimitrios Tzachanis, MD PhD • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
New drug cocktail shows promise in preventing transplant complications
Disease control CompletedThis study tested whether a combination of two drugs, cyclophosphamide and bortezomib, could prevent graft-versus-host disease (GVHD) in 23 adults with blood cancers who received a stem cell transplant. GVHD is a serious condition where donor cells attack the patient's body. The …
Matched conditions: GVHD
Phase: PHASE2 • Sponsor: NYU Langone Health • Aim: Disease control
Last updated Apr 29, 2026 15:04 UTC
-
Blood test may forecast deadly transplant complication
Knowledge-focused CompletedThis study looked at whether counting certain cells in the blood (called CECs) before a stem cell transplant can help predict if a patient will develop acute graft-versus-host disease (GVHD), a serious complication. Researchers enrolled 50 adults receiving their first stem cell t…
Matched conditions: GVHD
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC